Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Dan Ware, whose house caused a storm last year when it was posted on Twitter, says the Tories "care more about hardworking Brits"
Nepal is reeling with shock, on edge and waiting for help to arrive after it was hit by the worst earthquake disaster in over 80 years.
Former Newsnight presenter Jeremy Paxman has said he no longer watches the programme but revealed he's a fan of dating show Take Me Out